West Nile Virus in the Americas

Medical Clinics of North America

Volumn 92, Issue 6, 2008, Pages 1307-1322

  Petersen, Lyle R ^a   Hayes, Edward B ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

America; Arbovirus; Epidemiology; United States; West Nile virus

Indexed keywords

VACCINE;

BLOOD TRANSFUSION; CLINICAL FEATURE; DISEASE TRANSMISSION; MOSQUITO; NEUROLOGIC DISEASE; NORTH AMERICA; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ANIMALS; FLAVIVIRUS INFECTIONS; HUMANS; LATIN AMERICA; NORTH AMERICA; WEST INDIES; WEST NILE FEVER;

EID: 55049096521     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2008.07.004     Document Type: Review

References (107)

1. Asnis D.S., Conetta R., Teixeira A.A., et al. The West Nile virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis 30 3 (2000) 413-418
2. Nash D., Mostashari F., Fine A., et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344 24 (2001) 1807-1814
3. Mostashari F., Bunning M.L., Kitsutani P.T., et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 358 9278 (2001) 261-264
4. Gubler D.J. The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 45 8 (2007) 1039-1046
5. Mackenzie J.S., Gubler D.J., and Petersen L.R. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile, and dengue viruses. Nat Med 10 12 Suppl (2004) S98-S109
6. Lanciotti R.S., Ebel G.D., Deubel V., et al. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 298 1 (2002) 96-105
7. Chowers M.Y., Lang R., Nassar F., et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 7 4 (2001) 675-678
8. Brault A.C., Huang C.Y., Langevin S.A., et al. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat Genet 39 9 (2007) 1162-1166
9. Giladi M., Metzkor-Cotter E., Martin D.A., et al. West Nile encephalitis in Israel, 1999: the New York connection. Emerg Infect Dis 7 4 (2001) 659-661
10. Lanciotti R.S., Roehrig J.T., Deubel V., et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286 5448 (1999) 2333-2337
11. O'Leary D.R., Marfin A.A., Montgomery S.P., et al. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis Spring 4 1 (2004) 61-70
12. Lindsey N.P., Kuhn S., Campbell G.L., et al. West Nile virus neuroinvasive disease incidence in the United States, 2002-2006. Vector Borne Zoonotic Dis 8 1 (2008) 35-40
13. Petersen L.R., and Hayes E.B. Westward ho? The spread of West Nile virus. N Engl J Med 351 22 (2004) 2257-2259
14. Reisen W., and Brault A.C. West Nile virus in North America: perspectives on epidemiology and intervention. Pest Manag Sci 63 7 (2007) 641-646
15. Centers for Disease Control and Prevention. West Nile virus activity-United States, 2007. MMWR Morb Mortal Wkly Rep 2008;57(26):720-3.
16. Hadler J., Nelson R., McCarthy T., et al. West Nile virus surveillance in Connecticut in 2000: an intense epizootic without high risk for severe human disease. Emerg Infect Dis 7 4 (2001) 636-642
17. Paisley J.E., Hinckley A.F., O'Leary D.R., et al. West Nile virus infection among pregnant women in a northern Colorado community, 2003 to 2004. Pediatrics 117 3 (2006) 814-820
18. Murphy T.D., Grandpre J., Novick S.L., et al. West Nile virus infection among health-fair participants, Wyoming 2003: assessment of symptoms and risk factors. Vector Borne Zoonotic Dis 5 3 (2005) 246-251
19. Schweitzer B.K., Kramer W.L., Sambol A.R., et al. Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic. Clin Vaccine Immunol 13 3 (2006) 314-318
20. Mandalakas A.M., Kippes C., Sedransk J., et al. West Nile virus epidemic, northeast Ohio, 2002. Emerg Infect Dis 11 11 (2005) 1774-1777
21. Schellenberg T.L., Anderson M.E., Drebot M.A., et al. Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003. Can J Public Health 97 5 (2006) 369-373
22. Loeb M., Elliott S.J., Gibson B., et al. Protective behavior and West Nile virus risk. Emerg Infect Dis 11 9 (2005) 1433-1436
23. Centers for Disease Control and Prevention. West Nile virus activity-United States, 2006. MMWR Morb Mortal Wkly Rep 56 22 (2007) 556-559
24. Herring B.L., Bernardin F., Caglioti S., et al. Phylogenetic analysis of WNV in North American blood donors during the 2003-2004 epidemic seasons. Virology 363 1 (2007) 220-228
25. Davis C.T., Ebel G.D., Lanciotti R.S., et al. Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology 342 2 (2005) 252-265
26. Grinev A., Daniel S., Stramer S., et al. Genetic variability of West Nile virus in US blood donors, 2002-2005. Emerg Infect Dis 14 3 (2008) 436-444
27. Moudy R.M., Meola M.A., Morin L.L., et al. A newly emergent genotype of West Nile virus is transmitted earlier and more efficiently by Culex mosquitoes. Am J Trop Med Hyg 77 2 (2007) 365-370
28. Kilpatrick A.M., Meola M.A., Moudy R.M., Kramer L.D., et al. Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog (2008) 27;4(6):e100092
29. Drebot M.A., Lindsay R., Barker I.K., et al. West Nile virus surveillance and diagnostics: a Canadian perspective. Can J Infect Dis 14 2 (2003) 105-114
30. Komar N., and Clark G.G. West Nile virus activity in Latin America and the Caribbean. Rev Panam Salud Publica 19 2 (2006) 112-117
31. Beatty M.E., Hunsperger E., Long E., et al. Mosquito-borne infections after Hurricane Jeanne, Haiti, 2004. Emerg Infect Dis 13 2 (2007) 308-310
32. Bosch I., Herrera F., Navarro J.C., et al. West Nile virus, Venezuela. Emerg Infect Dis 13 4 (2007) 651-653
33. Diaz A.L., Komar N., Visintin A., et al. West Nile virus in birds, Argentina. Emerg Infect Dis 14 4 (2008) 689-691
34. Pupo M., Guzman M.G., Fernandez R., et al. West Nile Virus infection in humans and horses, Cuba. Emerg Infect Dis 12 6 (2006) 1022-1024
35. Deardorff E., Estrada-Franco J., Brault A.C., et al. Introductions of West Nile virus strains to Mexico. Emerg Infect Dis 12 2 (2006) 314-318
36. Beasley D.W., Davis C.T., Estrada-Franco J., et al. Genome sequence and attenuating mutations in West Nile virus isolate from Mexico. Emerg Infect Dis 10 12 (2004) 2221-2224
37. Owen J., Moore F., Panella N., et al. Migrating birds as dispersal vehicles for West Nile virus. EcoHealth 3 2 (2006) 79-85
38. Morales-Betoulle M.E., Morales H., Blitvich B.J., et al. West Nile virus in horses, Guatemala. Emerg Infect Dis 12 6 (2006) 1038-1039
39. Centers for Disease Control and Prevention. Detection of West Nile virus in blood donations-Puerto Rico, 2007. MMWR Morb Mortal Wkly Rep 2008;57(21):577-80.
40. Barrera R., Hunsperger E., Munoz-Jordan J.L., et al. First isolation of West Nile virus in the Caribbean. Am J Trop Med Hy 78 4 (2008) 666-668
41. Platt K.B., Tucker B.J., Halbur P.G., et al. Fox squirrels (Sciurus niger) develop West Nile virus viremias sufficient for infecting select mosquito species. Vector Borne Zoonotic Dis 8 2 (2008) 225-233
42. Platt K.B., Tucker B.J., Halbur P.G., et al. West Nile virus viremia in eastern chipmunks (Tamias striatus) sufficient for infecting different mosquitoes. Emerg Infect Dis 13 6 (2007) 831-837
43. Klenk K., Snow J., Morgan K., et al. Alligators as West Nile virus amplifiers. Emerg Infect Dis 10 12 (2004) 2150-2155
44. Nasci R.S., Savage H.M., White D.J., et al. West Nile virus in overwintering Culex mosquitoes, New York City, 2000. Emerg Infect Dis 7 4 (2001) 742-744
45. Reisen W.K., Fang Y., Lothrop H.D., et al. Overwintering of West Nile virus in Southern California. J Med Entomol 43 2 (2006) 344-355
46. Kilpatrick A.M., Kramer L.D., Jones M.J., et al. West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior. PLoS Biol 4 4 (2006) e82
47. Reisen W.K., Fang Y., and Martinez V.M. Effects of temperature on the transmission of West Nile virus by Culex tarsalis (Diptera: Culicidae). J Med Entomol 43 2 (2006) 309-317
48. El Adlouni S., Beaulieu C., Ouarda T.B., et al. Effects of climate on West Nile Virus transmission risk used for public health decision-making in Quebec. Int J Health Geogr 6 (2007) 40
49. Winters A.M., Bolling B.G., Beaty B.J., et al. Combining mosquito vector and human disease data for improved assessment of spatial West Nile virus disease risk. Am J Trop Med Hyg 78 4 (2008) 654-665
50. Brownstein J.S., Rosen H., Purdy D., et al. Spatial analysis of West Nile virus: rapid risk assessment of an introduced vector-borne zoonosis [erratum appears in Vector Borne Zoonotic Dis 2003;3(3):155]. Vector Borne Zoonotic Dis 2 3 (2002) 157-164
51. Ruiz M.O., Walker E.D., Foster E.S., et al. Association of West Nile virus illness and urban landscapes in Chicago and Detroit. Int J Health Geogr 6 (2007) 10
52. Orton S.L., Stramer S.L., and Dodd R.Y. Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors. Transfusion 46 2 (2006) 272-277
53. Miramontes Jr. R., Lafferty W.E., Lind B.K., et al. Is agricultural activity linked to the incidence of human West Nile virus?. Am J Prev Med 30 2 (2006) 160-163
54. Gu W., Lampman R., Krasavin N., et al. Spatio-temporal analyses of West Nile virus transmission in Culex mosquitoes in northern Illinois, USA, 2004. Vector Borne Zoonotic Dis 6 1 (2006) 91-98
55. LaBeaud A.D., Kile J.R., Kippes C., et al. Exposure to West Nile virus during the 2002 epidemic in Cuyahoga County, Ohio: a comparison of pediatric and adult behaviors. Public Health Rep 122 3 (2007) 356-361
56. Meyer T.E., Bull L.M., Cain Holmes K., et al. West Nile virus infection among the homeless, Houston, Texas. Emerg Infect Dis 13 10 (2007) 1500-1503
57. Gujral I.B., Zielinski-Gutierrez E.C., LeBailly A., et al. Behavioral risks for West Nile virus disease, northern Colorado, 2003. Emerg Infect Dis 13 3 (2007) 419-425
58. O'Leary D.R., Kuhn S., Kniss K.L., et al. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics 117 3 (2006) e537-e545
59. Pealer L.N., Marfin A.A., Petersen L.R., et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 349 13 (2003) 1236-1245
60. Iwamoto M., Jernigan D.B., Guasch A., et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 348 22 (2003) 2196-2203
61. Centers for Disease Control. Laboratory-acquired West Nile virus infections-United States, 2002. MMWR Morb Mortal Wkly Rep 51 50 (2002) 1133-1135
62. Nir Y., Beemer A., and Goldwasser R.A. West Nile virus infection in mice following exposure to a viral aerosol. Br J Exp Pathol 46 4 (1965) 443-449
63. Fonseca K., Prince G.D., Bratvold J., et al. West Nile virus infection and conjunctival exposure. Emerg Infect Dis 11 10 (2005) 1648-1649
64. Centers for Disease Control. Possible dialysis-related West Nile virus transmission-Georgia, 2003. MMWR Morb Mortal Wkly Rep 53 32 (2004) 738-739
65. Centers for Disease Control. West Nile virus infection among turkey breeder farm workers-Wisconsin, 2002. MMWR Morb Mortal Wkly Rep 52 42 (2003) 1017-1019
66. Hinckley A.F., OlLeary D.R., and Hayes E.B. Transmission of West Nile virus through human breast milk seems to be rare. Pediatrics 119 3 (2007) e666-e671
67. Biggerstaff B.J., and Petersen L.R. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion 43 8 (2003) 1007-1017
68. Busch M.P., Caglioti S., Robertson E.F., et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 353 5 (2005) 460-467
69. Centers for Disease Control. West Nile virus transmission through blood transfusion-South Dakota, 2006. MMWR Morb Mortal Wkly Rep 56 4 (2007) 76-79
70. Petersen L.R., and Epstein J.S. Problem solved? West Nile virus and transfusion safety. N Engl J Med 353 5 (2005) 516-517
71. Centers for Disease Control. West Nile virus infections in organ transplant recipients-New York and Pennsylvania, August-September, 2005. MMWR Morb Mortal Wkly Rep 54 40 (2005) 1021-1023
72. Alpert S.G., Fergerson J., and Noel L.P. Intrauterine West Nile virus: ocular and systemic findings. Am J Ophthalmol 136 4 (2003) 733-735
73. Brown J.A., Factor D.L., Tkachenko N., et al. West Nile viremic blood donors and risk factors for subsequent West Nile fever. Vector Borne Zoonotic Dis Winter 7 4 (2007) 479-488
74. Jean C.M., Honarmand S., Louie J.K., et al. Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis 13 12 (2007) 1918-1920
75. Murray K., Baraniuk S., Resnick M., et al. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect 134 6 (2006) 1325-1332
76. Patnaik J.L., Harmon H., and Vogt R.L. Follow-up of 2003 human West Nile virus infections, Denver, Colorado. Emerg Infect Dis 12 7 (2006) 1129-1131
77. Kumar D., Drebot M.A., Wong S.J., et al. A seroprevalence study of West Nile virus infection in solid organ transplant recipients. Am J Transplant 4 11 (2004) 1883-1888
78. Kumar D., Prasad G.V., Zaltzman J., et al. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation 77 3 (2004) 399-402
79. Chan C.K., Limstrom S.A., Tarasewicz D.G., et al. Ocular features of West Nile virus infection in North America: a study of 14 eyes. Ophthalmology 113 9 (2006) 1539-1546
80. Khairallah M., Yahia S.B., Letaief M., et al. A prospective evaluation of factors associated with chorioretinitis in patients with West Nile virus infection. Ocul Immunol Inflamm 15 6 (2007) 435-439
81. Abroug F., Ouanes-Besbes L., Letaief M., et al. A cluster study of predictors of severe West Nile virus infection. Mayo Clin Proc 81 1 (2006) 12-16
82. Lim J.K., Louie C.Y., Glaser C., et al. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. J Infect Dis 197 2 (2008) 262-265
83. Watson J.T., Pertel P.E., Jones R.C., et al. Clinical characteristics and functional outcomes of West Nile fever. Ann Intern Med 141 5 (2004) 360-365
84. Pepperell C., Rau N., Krajden S., et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in south central Ontario. CMAJ 168 11 (2003) 1399-1405
85. Sejvar J.J., Haddad M.B., Tierney B.C., et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 290 4 (2003) 511-515
86. Davis L.E., DeBiasi R., Goade D.E., et al. West Nile virus neuroinvasive disease. Ann Neurol 60 3 (2006) 286-300
87. Sejvar J.J. The long-term outcomes of human West Nile virus infection. Clin Infect Dis 44 12 (2007) 1617-1624
88. Hayes E.B., Sejvar J.J., Zaki S.R., et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 11 8 (2005) 1174-1179
89. Montgomery S.P., Chow C.C., Smith S.W., et al. Rhabdomyolysis in patients with West Nile encephalitis and meningitis. Vector Borne Zoonotic Dis 5 3 (2005) 252-257
90. Paddock C.D., Nicholson W.L., Bhatnagar J., et al. Fatal hemorrhagic fever caused by West Nile virus in the United States. Clin Infect Dis 42 11 (2006) 1527-1535
91. Hassin-Baer S., Kirson E.D., Shulman L., et al. Stiff-person syndrome following West Nile fever. Arch Neurol 61 6 (2004) 938-941
92. Sherman-Weber S., and Axelrod P. Central diabetes insipidus complicating West Nile encephalitis. Clin Infect Dis 38 7 (2004) 1042-1043
93. Bode A.V., Sejvar J.J., Pape W.J., et al. West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis 42 9 (2006) 1234-1240
94. Klee A.L., Maidin B., Edwin B., et al. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 10 8 (2004) 1405-1411
95. Peterson R.K., Macedo P.A., and Davis R.S. A human-health risk assessment for West Nile virus and insecticides used in mosquito management. Environ Health Perspect 114 3 (2006) 366-372
96. Schofield S., Tepper M., and Lalonde J. Comparing risk of West Nile Virus against risk of adulticiding. Environ Health Perspect 114 9 (2006) A519 [author reply: A519]
97. Carney R.M., Husted S., Jean C., et al. Efficacy of aerial spraying of mosquito adulticide in reducing incidence of West Nile virus, California, 2005. Emerg Infect Dis 14 5 (2008) 747-754
98. Petersen L.R., and Roehrig J.T. Flavivirus DNA vaccines-good science, uncertain future. J Infect Dis 196 12 (2007) 1721-1723
99. Zohrabian A., Hayes E.B., and Petersen L.R. Cost-effectiveness of West Nile virus vaccination. Emerg Infect Dis 12 3 (2006) 375-380
100. Monath T.P., Liu J., Kanesa-Thasan N., et al. A live, attenuated recombinant West Nile virus vaccine. Proc Natl Acad Sci U S A 103 17 (2006) 6694-6699
101. Martin J.E., Pierson T.C., Hubka S., et al. A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial. J Infect Dis 196 12 (2007) 1732-1740
102. Dauphin G., and Zientara S. West Nile virus: recent trends in diagnosis and vaccine development. Vaccine 25 30 (2007) 5563-5576
103. Reisen W.K., Fang Y., and Martinez V.M. Avian host and mosquito (Diptera: Culicidae) vector competence determine the efficiency of West Nile and St. Louis encephalitis virus transmission. J Med Entomol 42 3 (2005) 367-375
104. Fang Y., and Reisen W.K. Previous infection with West Nile or St. Louis encephalitis viruses provides cross protection during reinfection in house finches. Am J Trop Med Hyg 75 3 (2006) 480-485
105. Day J.F. Predicting St. Louis encephalitis virus epidemics: lessons from recent, and not so recent, outbreaks. Annu Rev Entomol 46 (2001) 111-138
106. Morales M.A., Barrandeguy M., Fabbri C., et al. West Nile virus isolation from equines in Argentina, 2006. Emerg Infect Dis 12 10 (2006) 1559-1561
107. Rico-Hesse R., Harrison L.M., Salas R.A., et al. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230 2 (1997) 244-251